Anti-CTLA-4 monoclonal antibodies
What are Anti-CTLA-4 monoclonal antibodies?
Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes. Anti-CTLA-4 monoclonal antibodies are directed to the inhibitory receptor CD152 (CTLA-4). They may be use to treat certain types of melanoma.
List of Anti-CTLA-4 monoclonal antibodies
View by Brand | Generic
|Drug Name||Avg. Rating||Reviews|
Generic name: ipilimumab
Generic name: tremelimumab
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|
Medical conditions associated with anti-CTLA-4 monoclonal antibodies:
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.